文献速递糖尿病肥胖与代谢综合征

体成分可区分糖尿病预防计划研究中的糖尿病前期表型聚类

Body Composition Differentiates Prediabetes Phenotype Clusters in the Diabetes Prevention Program Study.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

本研究对糖尿病预防计划临床试验中994名有体成分数据的参与者进行二次分析,采用无监督k均值聚类,基于常见临床危险因素单独或联合综合糖耐量及体成分指标,均得出5个聚类。仅用临床特征的模型对进展至2型糖尿病的时间预测准确性更高,但综合模型进一步按整体代谢健康区分了超重表型;两种模型在二甲双胍组中对2型糖尿病时间的区分度最大。

要点

  • 基于常见临床危险因素或联合糖耐量及体成分指标,均得出5个糖尿病前期表型聚类。
  • 仅用临床特征的模型对进展至2型糖尿病的时间预测准确性更高。
  • 综合模型进一步按整体代谢健康区分超重表型;两种模型在二甲双胍组中区分度最大。

核心结论

  • 数据驱动的聚类可识别进展风险更高且对风险降低干预有不同反应的糖尿病前期表型,进一步研究表型差异可能有助于个体化预防和治疗选择。

研究设计与样本

  • 糖尿病预防计划临床试验的二次分析,纳入有体成分测量的参与者994名,采用无监督k均值聚类分析。

主要发现

  • 基于常见临床特征和基于综合糖耐量及体成分指标两种建模方法均得出5个聚类,各聚类内参与者个体危险因素水平显著不同。
  • 仅用临床特征的模型对进展至2型糖尿病的时间预测准确性更高,而综合模型进一步按整体代谢健康区分了超重表型。
  • 两种模型中,对2型糖尿病时间的最大区分度均出现在二甲双胍组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Type 2 diabetes (T2D) remains a significant public health problem, and current approaches to risk reduction fail to adequately prevent T2D in all individuals. OBJECTIVE: The purpose of this study was to apply clustering methods that include metabolic risk factors and body composition measures to identify and characterize prediabetes phenotypes and their relationships with treatment arm and incident T2D. DESIGN: Secondary analysis of the Diabetes Prevention Program clinical trial. SETTING: Previously completed Diabetes Prevention Program trial. PATIENTS OR OTHER PARTICIPANTS: Subset of participants (n = 994) with body composition measures. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Unsupervised k-means clustering analysis was applied to derive the optimal number of clusters of participants based on common clinical risk factors alone or common risk factors plus more comprehensive measures of glucose tolerance and body composition. RESULTS: Five clusters were derived from both the common clinical characteristics and the addition of comprehensive measures of glucose tolerance and body composition. Within each modeling approach, participants showed significantly different levels of individual risk factors. The clinical only model showed higher accuracy for time to T2D; however, the more comprehensive models further differentiated an overweight phenotype by overall metabolic health. For both models, the greatest differentiation in determining time to T2D was in the metformin arm of the trial. CONCLUSION: Data-driven clustering of patients with prediabetes allows for identification of prediabetes phenotypes at greater risk for disease progression and responses to risk reduction interventions. Further investigation into phenotypic differences in treatment response could enable better personalization of prediabetes and T2D prevention and treatment choices.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Stroebel BM, Gadgil M, Lewis KA, et al. Body Composition Differentiates Prediabetes Phenotype Clusters in the Diabetes Prevention Program Study. J Clin Endocrinol Metab. 2025. PMID: 40067970. doi:10.1210/clinem/dgaf163

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。